Can a stronger dose of eye injections keep vision stable longer?

NCT ID NCT07390253

First seen Feb 05, 2026 · Last updated May 14, 2026 · Updated 14 times

Summary

This study looks at whether switching people with wet age-related macular degeneration (AMD) from the standard 2mg dose of Aflibercept to a higher 8mg dose can allow longer breaks between eye injections while still keeping vision stable. About 50 adults who have already had at least four injections of the 2mg dose will be followed for 12 months. The goal is to see if the higher dose reduces the number of injections needed without harming eyesight.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Vienna Institute for Research in Ocular Surgery

    Vienna, 1140, Austria

Conditions

Explore the condition pages connected to this study.